Annie Eng

Annie Eng is the Founder and CEO of InnoBioscience, a clinical-stage biopharmaceutical company established in July 2013, focused on developing innovative therapies for conditions such as Auto-Immune Disease, Multiple Sclerosis, and Alzheimer Disease. Additionally, Annie Eng founded and serves as CEO of HP Ingredients, a nutraceutical company launched in January 2002 that specializes in unique, research-backed products. From January 2008 to December 2011, Annie Eng also served as Founder and CEO of Novelle International, aimed at promoting health through natural plant-based medicine, supported by scientific research. Prior to these ventures, Annie Eng worked as VP of Investment at Gruntal & Co from January 1994 to June 2001. Educational qualifications include a degree from the University of Wisconsin-Madison, completed in 1994.